This inventor holds 2 USPTO granted patents. Top assignees: Sk Holding Co., Ltd., Sk Holdings Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Inventor Hunwoo Shin
Introduction
Hunwoo Shin is a notable inventor based in Livingston, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a focus on developing treatments for diabetes and lipid disorders, he holds 2 patents that showcase his innovative approach to medical science.
Latest Patents
Hunwoo Shin's latest patents include "Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use." This invention concerns racemic or enantiomerically enriched substituted carboxylic acids and their derivatives, which are represented by a specific formula. The invention also encompasses pharmaceutical compositions that include an effective amount of these compounds mixed with pharmaceutically acceptable carriers or excipients. Additionally, his patent titled "Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders" discloses derivatives of 3-chromancarboxylic acid, which are useful for treating non-insulin dependent diabetes mellitus (type II diabetes) and related vascular diseases, as well as obesity and lipid disorders.
Career Highlights
Throughout his career, Hunwoo Shin has worked with prominent companies, including SK Holdings Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.
Collaborations
Hunwoo Shin has collaborated with notable professionals in his field, including Yong Moon Choi and Palanichamy Ilankumaran. These collaborations have likely enhanced his research and development efforts.
Conclusion
Hunwoo Shin's innovative work in developing pharmaceutical treatments for diabetes and lipid disorders highlights his significant contributions to medical science. His patents reflect a commitment to improving health outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile